Japan's Mid-Size Pharmas Tackle Orphan Drugs Larger Firms Ignore
This article was originally published in PharmAsia News
Executive Summary
Japan's mid-size drug makers, such as Mochida Pharmaceutical, Aska Pharmaceutical and Kyorin Holdings are moving to fill a pharmaceutical gap for digestive system disorders ignored by leading drug